These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36590148)

  • 21. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
    Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q
    Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Unique Surgical Case of Mixed Metaplastic Breast Carcinoma With Heterologous Mesenchymal Differentiation and Conventional Adenocarcinomatous Elements.
    Okanemasa Y; Shioya A; Kumagai M; Takata M; Tsubata Y; Han J; Terauchi T; Morioka E; Inokuchi M; Yamada S
    Cureus; 2024 Mar; 16(3):e55926. PubMed ID: 38601424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.
    Gobbini E; Ezzalfani M; Dieras V; Bachelot T; Brain E; Debled M; Jacot W; Mouret-Reynier MA; Goncalves A; Dalenc F; Patsouris A; Ferrero JM; Levy C; Lorgis V; Vanlemmens L; Lefeuvre-Plesse C; Mathoulin-Pelissier S; Petit T; Uwer L; Jouannaud C; Leheurteur M; Lacroix-Triki M; Cleaud AL; Robain M; Courtinard C; Cailliot C; Perol D; Delaloge S
    Eur J Cancer; 2018 Jun; 96():17-24. PubMed ID: 29660596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
    Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
    Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review.
    Wu J; Jin Y; Liu M; Zhu N; Jing Z; Zeng X
    Breast Cancer (Dove Med Press); 2023; 15():39-45. PubMed ID: 36698553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metaplastic Breast Cancer: Current Understanding and Future Directions.
    Thomas A; Douglas E; Reis-Filho JS; Gurcan MN; Wen HY
    Clin Breast Cancer; 2023 Dec; 23(8):775-783. PubMed ID: 37179225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.
    Ottini L; Silvestri V; Rizzolo P; Falchetti M; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D
    Breast Cancer Res Treat; 2012 Jul; 134(1):411-8. PubMed ID: 22527108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic Features of Metaplastic Breast Carcinoma: Experience From a Tertiary Cancer Center of North India.
    Damera VV; Chowdhury Z; Tripathi M; Singh R; Verma RK; Jain M
    Cureus; 2022 Sep; 14(9):e28978. PubMed ID: 36237767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.
    Deluche E; Antoine A; Bachelot T; Lardy-Cleaud A; Dieras V; Brain E; Debled M; Jacot W; Mouret-Reynier MA; Goncalves A; Dalenc F; Patsouris A; Ferrero JM; Levy C; Lorgis V; Vanlemmens L; Lefeuvre-Plesse C; Mathoulin-Pelissier S; Petit T; Uwer L; Jouannaud C; Leheurteur M; Lacroix-Triki M; Courtinard C; Perol D; Robain M; Delaloge S
    Eur J Cancer; 2020 Apr; 129():60-70. PubMed ID: 32135312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.
    Joneja U; Vranic S; Swensen J; Feldman R; Chen W; Kimbrough J; Xiao N; Reddy S; Palazzo J; Gatalica Z
    J Clin Pathol; 2017 Mar; 70(3):255-259. PubMed ID: 27531819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and overall survival prognostic nomogram for metaplastic breast cancer.
    Zheng C; Fu C; Wen Y; Liu J; Lin S; Han H; Han Z; Xu C
    Front Oncol; 2023; 13():1030124. PubMed ID: 36937402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
    Ong CT; Campbell BM; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hall A; Hyslop T; Hwang ES; Fayanju OM
    Ann Surg Oncol; 2018 Aug; 25(8):2249-2260. PubMed ID: 29855830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metaplastic breast cancer: clinicopathological features and its prognosis.
    Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
    J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of metastasis patterns on survival in male patients with different breast cancer subtypes: results from the Surveillance, Epidemiology, and End Results (SEER) database.
    Zhou W; Wang SP; Zeng W; Chen SC; Huang YH; Zhou L; Wang M; Wei W; Zhang C; Liu ZM; Guo L
    Transl Cancer Res; 2020 Apr; 9(4):2267-2279. PubMed ID: 35117587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US.
    Elimimian EB; Samuel TA; Liang H; Elson L; Bilani N; Nahleh ZA
    JAMA Netw Open; 2021 Apr; 4(4):e214123. PubMed ID: 33844001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
    Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
    Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
    Zhao J; Wang B; Zhao J; Mao Y; Liu J; Yang Y
    Thorac Cancer; 2020 Nov; 11(11):3107-3116. PubMed ID: 32930510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metaplastic breast cancer: Treatment and prognosis by molecular subtype.
    Hu J; Zhang H; Dong F; Zhang X; Wang S; Ming J; Huang T
    Transl Oncol; 2021 May; 14(5):101054. PubMed ID: 33677236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
    Deb S; Jene N; ; Fox SB
    BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.